Tune in to this week’s podcast to hear the exceptional scholar’s perspective on the future of the science and treatment of mood disorders which vastly burden our society.
Professor Allan Young is a psychopharmacologist and the Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Prof Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic.
Professor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders like depression. He has received research grant funding from the UK Medical Research Council, the Wellcome Trust, and numerous other respected funding agencies worldwide. He has published over 400 peer-reviewed publications and a number of books about psychopharmacology and affective disorders.According to the 2014 Thomson Reuters Highly Cited Researcher list, Professor Young was recently ranked as one of the world’s leading scientific minds in the field of Psychiatry and Psychology.
Esketamine: Ketamine nasal spray